06 Gene editing bill: encouraging innovation or adding complexity?
08 Solving the PCT Priority problem
09 G 2/21: how to support inventive steps in patentability
10 A guide for life sciences entrepreneurs
11 The fall of COVID-19 and the rise of antimicrobial resistance
12 Predicting the unpredictable during pregnancy
13 Pandemic blues: the global approach to COVID-related IP
14 Psychedelics: from fungi and plants to patents
15 When alliances fail, is arbitration the answer?